Researchers from the Australian Institute for Bioengineering and Nanotechnology (AIBN) have won $1.5 million to improve precision nanomedicines and create a cleaner environment – all while strengthening industry ties.
As we close the book on 2022 it is time to look at how far the AIBN has come during the year, and how we are setting ourselves up for an even bigger 2023.
An Australian-first research and manufacturing hub at the University of Queensland will lead the design and development of the next-generation of treatments for cancer patients.
AIBN's Professor Kristofer Thurecht and IMB's Professor Robert Parton and are Eureka Prize finalists for their project using VR to solve the problem of visualising complex data.
Cancer research projects at the Australian Institute for Bioengineering and Nanotechnology at UQ are beneficiaries in the latest round of National Health and Medical Research Council funding.
